Middle Meningeal Artery Embolization for the Treatment of Subdural Hematomas With TRUFILL® n-BCA

计划入组 376 人 · 首次发布于 2021 年 3 月 25 日

MMA Embolization for Refractory Chronic Migraine

计划入组 70 人 · 首次发布于 2024 年 12 月 16 日

Study Comparing Onyx and TRUFILL in Brain Arteriovenous Malformations (AVMs)

计划入组 117 人 · 首次发布于 2009 年 3 月 9 日

BCA-902

BCA-356

BCA-901

N&N Pharmaceuticals, Inc.

United States

n-Lorem Foundation

United States

Steve N Caritis Md

United States

FDA Approves Expanded Indication for Johnson & Johnson's TRUFILL n-BCA System in Chronic Subdural Hematoma Treatment

MEMBRANE Trial Demonstrates Benefits of MMA Embolization in Chronic Subdural Hematoma Treatment

Novel AI Model PROGRxN-BCa Significantly Improves NMIBC Progression Risk Prediction